R1 Therapeutics Funding: $78M Raised, Series A (2026)
R1 Therapeutics is based in Redwood City, California. It has raised $78M in total funding. Latest round: Series A.
R1 Therapeutics funding overview
R1 Therapeutics is based in Redwood City, California. R1 Therapeutics has raised $78M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2026. The round record for R1 Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include Abingworth, F-Prime Capital, DaVita Venture Group, Curie.Bio, SymBiosis, U.S. Renal Care. 6 distinct backers are named across the disclosed rounds.
R1 Therapeutics at a glance
Total raised
$78M
Latest round
Series A
Latest round date
March 2026
Headquarters
Redwood City, California
Notable investors
Abingworth, F-Prime Capital, DaVita Venture Group, Curie.Bio, SymBiosis, U.S. Renal Care
Frequently asked about R1 Therapeutics funding
How much has R1 Therapeutics raised?
R1 Therapeutics has raised $78M in total disclosed funding across the rounds on record.
Who has invested in R1 Therapeutics?
Abingworth, F-Prime Capital, DaVita Venture Group, Curie.Bio, SymBiosis, U.S. Renal Care are named among the investors backing R1 Therapeutics.
What was the latest R1 Therapeutics funding round?
The most recent disclosed round is a Series A, announced in March 2026.
Where is R1 Therapeutics based?
R1 Therapeutics is based in Redwood City, California.
When did R1 Therapeutics last raise?
The last disclosed R1 Therapeutics round closed in March 2026 at Series A.
Round data for R1 Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Redwood City and backer lists below.
